May 21, 2019

Why Bernie Sanders is crashing Walmart's annual shareholders' meeting

Sen. Bernie Sanders in Iowa. Photo: Stephen Maturen/Getty Images

Over the years, Walmart's bosses have invited dozens of A-listers, including Justin Timberlake, Jamie Foxx and Carly Rae Jepsen, to its annual shareholders' meeting in Bentonville, Arkansas. This year, workers, who are attending the meeting to lobby for higher pay and better benefits, invited their own guest: Sen. Bernie Sanders.

Why it matters: In the 1980s, Walmart was the archvillain of capitalism. Now, Amazon has largely taken its place, fielding most of the criticism from political candidates and academics for its size and influence. But Walmart, which is still far bigger by sales volume than Amazon, is starting to creep back into the debate.

Details:

  • Sanders is attending the June 5 meeting to stand with workers as they introduce a proposal asking for a seat on the company's board for hourly workers.
  • Last year, Walmart CEO Doug McMillon made $23.6 million. That's 1,076 times more than the median salary of hourly workers, which was $22,000, according to a Washington Post analysis of company filings.
  • Sanders told the Post: "If hourly workers at Walmart were well represented on its board, I doubt you would see the CEO of Walmart making over a thousand times more than its average worker."

Walmart told Axios: "The company will respond to specific shareholder proposals once they are formally presented. ... If Sen. Sanders attends, we hope he will approach his visit not as a campaign stop, but as a constructive opportunity to learn about the many ways we’re working to provide increased economic opportunity, mobility and benefits to our associates."

Go deeper: Walmart wants to be the anti-Amazon

Go deeper

International coronavirus treatment trial uses AI to speed results

Hydroxychloroquine is one of the drugs that will be included in the trial. Photo: John Philips/Getty Images

The first hospital network in the U.S. has joined an international clinical trial using artificial intelligence to help determine which treatments for patients with the novel coronavirus are most effective on an on-going basis.

Why it matters: In the midst of a pandemic, scientists face dueling needs: to find treatments quickly and to ensure they are safe and effective. By using this new type of adaptive platform, doctors hope to collect clinical data that will help more quickly determine what actually works.

We can't just flip the switch on the coronavirus

Illustration: Sarah Grillo/Axios

It feels like some big, terrible switch got flipped when the coronavirus upended our lives — so it’s natural to want to simply flip it back. But that is not how the return to normalcy will go.

The big picture: Even as the number of illnesses and deaths in the U.S. start to fall, and we start to think about leaving the house again, the way forward will likely be slow and uneven. This may feel like it all happened suddenly, but it won't end that way.

Go deeperArrow24 mins ago - Health

The Fed rescues Wall Street, but Main Street is another story

llustration: Aïda Amer/Axios

In less than a month, the Federal Reserve has unleashed a multi-trillion dollar tour de force to buoy the U.S. economy against the COVID-19 pandemic.

Why it matters: While it has steadied the markets, the Fed is poorly equipped to offset the hit being absorbed by small business owners and the close to 17 million Americans who have filed for unemployment in just the past three weeks.